Agilent Technologies: Q4 Earnings Insights


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Shares of Agilent Technologies (NYSE:A) fell 2.53% in after-market trading after the company reported Q4 results.

Quarterly Results

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Earnings per share rose 10.11% over the past year to $0.98, which beat the estimate of $0.93.

Revenue of $1,483,000,000 higher by 8.49% from the same period last year, which beat the estimate of $1,400,000,000.

Guidance

Agilent Sees Q1 Adj. EPS $0.85-$0.88 vs $0.88 Est., Sales $1.42B-$1.43B vs $1.4B Est.; Sees FY21 Adj. EPS $3.57-$3.67 vs $3.68 Est., Sales $5.6B-$5.7B vs $5.67B Est.

Details Of The Call


Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


Date: Nov 23, 2020

Time: 04:30 PM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fwww.investor.agilent.com%2F&eventid=2626386&sessionid=1&key=606DDF936B1155263C494F86F6F156DF®Tag=&sourcepage=register

Recent Stock Performance

52-week high: $117.50

52-week low: $61.13

Price action over last quarter: Up 10.88%

Company Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2019 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (31%) and China (20%) representing the largest country concentrations.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Earnings